About 70 percent of Americans with history of heart disease, stroke take aspirin
the ONA take:
About 70% of Americans who have heart disease or a stroke regularly take low-dose aspirin, according to a report from the U.S. Centers for Disease Control and Prevention (CDC).
For the study, researchers from the U.S. CDC analyzed data from the 2013 Behavioral Risk Factor Surveillance System, which included patients surveyed via telephone from 20 states and the District of Columbia. They found that 70.8% of respondents take low-dose aspirin regularly. More importantly, nearly 94% of those with a history of heart problems reported taking low-dose aspirin regularly to prevent a heart attack
In addition, approximately 80% reported taking it for stroke prevention and 76% said they take it to prevent both. Only 4% of respondents reporting taking low-dose aspirin for pain relief only.
Mississippi had the highest aspirin use with 72% of patients with heart problems regularly taking low-dose aspirin. Missouri had the lowest with 44%. Researchers found the males, people 65 years and older, whites, and patients with at least two cardiac risk factors are more likely to take aspirin compared with other groups.
The findings suggest that clinicians should target patients reporting lower regular aspirin use like Hispanics, blacks, and those who did not attain a high school diploma.
About 70% of Americans who have heart disease or a stroke regularly take low-dose aspirin.
Sign Up for Free e-newsletters
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Fosfomycin Effective Alternate for Febrile Neutropenia Prophylaxis
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Breast Implants Associated With Increased Risk of Breast Anaplastic Large-cell Lymphoma
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- OS Similar With Gemcitabine Plus S-1 vs Standard Therapy for Biliary Tract Cancer
- Feasibility and Outcomes of Modified Enhanced Recovery After Surgery for Nursing Management of Aged Patients Undergoing Esophagectomy
- Urine Drug Testing Policy Can Assist Opioid Treatment Decisions
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|